Quick Overview: In this interview, filmed at the 2018 conference, At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, ... his group in Brisbane on DNA damage repair proteins that are emerging as biomarkers and targets in lung cancer,

Kenneth O Byrne On The - Detailed Overview & Context

In this interview, filmed at the 2018 conference, At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, ... his group in Brisbane on DNA damage repair proteins that are emerging as biomarkers and targets in lung cancer, A short video on lung cancer research at the Princess Alexandra Hospital campus with patient Michel Itel, Professor

Photo Gallery

Kenneth O'Byrne on the IASLC 18th World Conference on Lung Cancer.
The importance of BTOG
Translational research: targeting cancer genetics and dependencies
Predictive models of tumor response to chemotherapy and radiotherapy in NSCLC
Checkpoint inhibitor resistance in lung cancer
Recent developments in limited-stage small cell lung cancer
The tumor microenvironment: lung cancer
The evolution of BTOG and thoracic oncology care in the UK
mLIPI as a predictor of nivolumab outcomes in advanced NSCLC
Promising updates in small cell lung cancer at WCLC 2025
Cancer and ageing: the future of care
Targeting oncogenes in NSCLC
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored